Sample ID | Biosample type | Tissue type | Biosample name | TF Frequency |
---|---|---|---|---|
Sample_02_191 | Cell line | Stomach | SNU719 | 0.42857142857143 |
Sample_02_237 | Cell line | Colon | V389 | 0.43025952512424 |
Sample_02_241 | Cell line | Colon | V456 | 0.37020316027088 |
Sample_02_242 | Cell line | Colon | V481 | 0.3358969428956 |
Sample_02_354 | Cell line | Colon | Colo205 | 0.42192192192192 |
Sample_02_355 | Cell line | Colon | HCT15 | 0.375 |
Sample_02_358 | Cell line | Colon | LS180 | 0.62282780410742 |
Sample ID | Tissue type | Biosample type | Biosample name |
---|---|---|---|
Sample_02_237 | Colon | Cell line | V389 |
Sample_02_241 | Colon | Cell line | V456 |
Sample_02_354 | Colon | Cell line | Colo205 |
Sample_02_358 | Colon | Cell line | LS180 |
TF_name | Disease_name | Disease_class | Disease_semantic_type | TF_disease_source |
---|---|---|---|---|
ASCL2 | Malignant tumor of colon | C04;C06 | Neoplastic Process | CTD_human |
ASCL2 | Colonic Neoplasms | C04;C06 | Neoplastic Process | CTD_human |
pathway_ID | pathway_name | pathway_source | gene_number | edge_number |
---|
GO_term_name | GO_term_type | TF_name |
---|---|---|
GO_NEGATIVE_REGULATION_OF_GLIOGENESIS | BP | ASCL2 |
GO_SPONGIOTROPHOBLAST_LAYER_DEVELOPMENT | BP | ASCL2 |
GO_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT | BP | ASCL2 |
GO_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT | BP | ASCL2 |
GO_REGULATION_OF_GLIAL_CELL_PROLIFERATION | BP | ASCL2 |
GO_REPRODUCTIVE_SYSTEM_DEVELOPMENT | BP | ASCL2 |
GO_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION | BP | ASCL2 |
GO_RESPONSE_TO_OXYGEN_LEVELS | BP | ASCL2 |
GO_MAINTENANCE_OF_CELL_NUMBER | BP | ASCL2 |
GO_REGULATION_OF_GLIOGENESIS | BP | ASCL2 |
GO_REGULATION_OF_CELL_DEVELOPMENT | BP | ASCL2 |
GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_BINDING | MF | ASCL2 |
GO_E_BOX_BINDING | MF | ASCL2 |
GO_TRANSCRIPTIONAL_REPRESSOR_ACTIVITY_RNA_POLYMERASE_II_CORE_PROMOTER_PROXIMAL_REGION_SEQUENCE_SPECIFIC_BINDING | MF | ASCL2 |